Showing 2881-2900 of 8668 for: Cochrane Systematic Reviews Back
- Fluoxetine for adults who are overweight or obese
Cochrane Systematic Reviews, 15-Oct-2019
Fluoxetine is a serotonin reuptake inhibitor indicated for major depression. It is also thought to affect weight control: this seems to happen through appetite changes resulting in decreased food intake and normalisation of unusual eating behaviours. Howe
- Fluoxetine versus other types of pharmacotherapy for depression
Cochrane Systematic Reviews, 17-Jul-2013
Depression is common in primary care and is associated with marked personal, social and economic morbidity, thus creating significant demands on service providers. The antidepressant fluoxetine has been studied in many randomised controlled trials (RCTs)
- Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
Cochrane Systematic Reviews, 10-Jun-2014
Long-acting depot injections of drugs such as flupenthixol decanoate are extensively used as a means of long-term maintenance treatment for schizophrenia.
- Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 29-Jul-2014
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic drugs, however, low-potency antipsychotic drugs are sometimes perceived as less efficacious than high-po
- Flupenthixol versus placebo for schizophrenia
Cochrane Systematic Reviews, 11-Sep-2012
Flupenthixol, first made available in the UK in 1965, has been used as a treatment for schizophrenia for decades.
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 2-Jul-2016
Fluphenazine is a typical antipsychotic drug from the phenothiazine group of antipsychotics. It has been commonly used in the treatment of schizophrenia, however, with the advent of atypical antipsychotic medications, use has declined over the years.
- Fluphenazine (oral) versus placebo for schizophrenia
Cochrane Systematic Reviews, 12-Jun-2018
Fluphenazine is one of the first drugs to be classed as an 'antipsychotic' and has been widely available for five decades.
- Fluphenazine decanoate (depot) and enanthate for schizophrenia
Cochrane Systematic Reviews, 25-Feb-2016
Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance. The benefits gained by long-acting preparations, however, may be offset by a higher incidence of adverse effects.
- Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 28-Jul-2014
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however, low-potency antipsychotic drugs are often perceived as less efficacious th
- Fluticasone at different doses for chronic asthma in adults and children
Cochrane Systematic Reviews, 8-Oct-2008
Inhaled fluticasone propionate (FP) is a high-potency inhaled corticosteroid used in the treatment of asthma.
- Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
Cochrane Systematic Reviews, 17-Oct-2007
Beclomethasone dipropionate (BDP) and budesonide (BUD) are commonly prescribed inhaled corticosteroids for the treatment of asthma. Fluticasone propionate (FP) is newer agent with greater potency in in-vitro assays.
- Fluticasone versus 'extrafine' HFA‐beclomethasone dipropionate for chronic asthma in adults and children
Cochrane Systematic Reviews, 19-Apr-2006
The relative efficacy of fluticasone (FP) and beclomethasone (BDP) propelled with CFCs has been well established. The potency of HFA-BDP is thought to have been improved with new propellant and some studies suggest that extra-fine HFA-BDP may be equipoten
- Fluticasone versus placebo for chronic asthma in adults and children
Cochrane Systematic Reviews, 8-Oct-2008
Inhaled fluticasone propionate (FP) is a relatively new inhaled corticosteroid for the treatment of asthma.
- Fluvastatin for lowering lipids
Cochrane Systematic Reviews, 6-Mar-2018
Fluvastatin is thought to be the least potent statin on the market, however, the dose-related magnitude of effect of fluvastatin on blood lipids is not known.
- Fluvoxamine versus other anti-depressive agents for depression
Cochrane Systematic Reviews, 30-Sep-2013
Fluvoxamine, one of the oldest selective serotonin reuptake inhibitors (SSRIs), is prescribed to patients with major depression in many countries. Several studies have previously reviewed the efficacy and tolerability of fluvoxamine for the treatment of m
- Fly control to prevent diarrhoea in children
Cochrane Systematic Reviews, 17-Dec-2018
Diarrhoeal disease accounts for millions of child deaths every year. Although the role of flies as vectors of infectious diarrhoea has been established, fly control is not often mentioned as an approach to decrease childhood diarrhoea. Theoretically, fly
- Foam dressings for healing diabetic foot ulcers
Cochrane Systematic Reviews, 6-Jun-2013
Foot ulcers in people with diabetes are a prevalent and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from. A clear and current overview of current evidence is
- Foam dressings for treating pressure ulcers
Cochrane Systematic Reviews, 12-Oct-2017
Pressure ulcers, also known as pressure injuries and bed sores, are localised areas of injury to the skin or underlying tissues, or both. Dressings made from a variety of materials, including foam, are used to treat pressure ulcers. An evidence-based over
- Foam dressings for venous leg ulcers
Cochrane Systematic Reviews, 26-Jun-2013
Venous leg ulcers are a common and recurring type of chronic or complex wound that are associated with considerable cost to patients and to healthcare providers. Primary wound contact dressings are usually applied beneath compression devices with the aim
- Foam surfaces for preventing pressure ulcers
Cochrane Systematic Reviews, 6-May-2021
Pressure ulcers (also known as pressure injuries) are localised injuries to the skin or underlying soft tissue, or both, caused by unrelieved pressure, shear or friction. Foam surfaces (beds, mattresses or overlays) are widely used with the aim of prevent
